ABSTRACT
In December 2022 (from 00: 00, 1 December to 24: 00, 31 December), except COVID-19, a total of 278 907 cases of notifiable communicable diseases, including 2 384 deaths, were reported in China (except Hong Kong, Macao Special Administrative Regions and Taiwan Province, the same below). In communicable diseases in class A, no cases and no deaths were reported. In communicable diseases in class B, no cases and no deaths of severe acute respiratory syndrome, poliomyelitis, human infection with highly pathogenic avian influenza virus, diphtheria and human infection with avian influenza A (H7N9) virus were reported. For the remaining 21 communicable diseases except COVID-19 in class B, a total of 148 573 cases were reported, a decrease of 29% compared with last month (210 178 cases) and a decrease of 46% compared with the same period in 2021 (273 361 cases). The first 5 diseases in terms of reported case number were viral hepatitis, pulmonary tuberculosis, syphilis, gonorrhea and AIDS, accounting for 96% of the total reported cases in class B. A total of 2 384 deaths were reported, an increase of 28% (521 deaths) compared with last month (1 863 deaths) and a decrease of 14% compared with the same period in 2021 (2 763 deaths). In class C communicable diseases, a total of 130 334 cases were reported, a decrease of 33% compared with last month (195 072 cases) and a decrease of 69% compared with the same period in 2021 (420 015 cases). The first 3 diseases in terms of reported case number were influenza, other infectious diarrhea, and hand foot and mouth disease (HFMD), accounting for 96% of the total reported cases in class C. Compared with last month, except filariasis which had no incidence, the reported case number of leprosy was same, and the disease with reported case increase was echinococcosis (47 cases, 48%), the reported cases of other diseases all decreased, the first 3 diseases with reported case decreases were HFMD (22 886 cases, 45%), other infectious diarrhea (21 962 cases, 43%) and influenza (14 775 cases, 18%). Compared with the same period in 2021, except filariasis which had no incidence, the reported cases of other diseases all decreased, the first 3 diseases with reported case decreases were influenza (181 158 cases, 73%), other infectious diarrhea (53 502 cases, 65%) and HFMD (46 674 cases, 63%). No death caused by class C communicable disease was reported, same to last month and a decrease of 7 deaths compared with the same period in 2021 (7 deaths).
ABSTRACT
Objective: To assess the changes in the sexual behavior of Egyptian married men during the COVID-19 lockdown period. Methods: In a cross-sectional study, the sexual behavior of 164 Egyptian married men was examined through an online questionnaire, designed by the authors, and uploaded to strictly male social media groups using Google Forms. The questionnaire included demographic and clinical variables about age, stress level about COVID-19, fear of infection during sexual relations and also compared sexual behavior before the COVID-19 lockdown. Results: 39.17% of the sample reported decrease in sexual desire, 28.05% reported decrease in sexual frequency, 17.68% reported decrease in sexual satisfaction and 22% reported fear of infection with COVID-19 during sexual relations. Severe stress about COVID-19, increased rate of marital conflicts and fear of infection with COVID-19 during sexual relations were significantly associated with decreased sexual desire, frequency and satisfaction. Conclusions: This study demonstrated severe stress about COVID-19, increased rate of marital conflict and fear of infection with COVID-19 during sexual activity, all of which were significantly associated with decreased levels of sexual desire, frequency and satisfaction respectively among married Egyptian men during the COVID-19 lockdown period. Promoting education to manage stress, decreasing marital conflicts and the correction of the mistaken belief that COVID-19 is a sexually transmitted disease is highly important to promote healthy sexual relations during the COVID-19 pandemic and lockdown period.